Can HIFU Replace Surgery? New 10-Year Prostate Cancer Data

3 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

Published
Welcome to UroNurse News, hosted by Vic Senese, RN, BSN, FAUNA.

A landmark study published in European Urology followed 3,477 men with localized, nonmetastatic prostate cancer treated with High-Intensity Focused Ultrasound (HIFU) or cryotherapy. With follow-up extending to 10 years, researchers found remarkably low prostate cancer-specific mortality and durable cancer control in carefully selected patients.

In this episode, you'll learn:

• What focal therapy is and how it differs from surgery and radiation
• Who may qualify for HIFU or cryotherapy
• The impressive 10-year survival and metastasis outcomes
• Why some patients required repeat focal therapy or later radical treatment
• The strengths and limitations of this important registry study
• How these findings may influence the future of prostate cancer management

Whether you're a urology nurse, advanced practice provider, physician, resident, or a patient wanting to stay informed, this episode explains the latest evidence in an easy-to-understand format.

Categoria
Urology
Commenta per primo questo video.

Prossimo